
Erica S Y Lin
Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2861 |
| Total Applications | 1103 |
| Issued Applications | 882 |
| Pending Applications | 99 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13690045
[patent_doc_number] => 20170355977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => OPTOGENETIC TOOL FOR RAPID AND REVERSIBLE CLUSTERING OF PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/618345
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618345 | Optogenetic tool for rapid and reversible clustering of proteins | Jun 8, 2017 | Issued |
Array
(
[id] => 13399909
[patent_doc_number] => 20180251497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => DISORDERED PROTEIN-BASED SEEDS FOR MOLECULAR CLUSTERING
[patent_app_type] => utility
[patent_app_number] => 15/618361
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618361
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618361 | Disordered protein-based seeds for molecular clustering | Jun 8, 2017 | Issued |
Array
(
[id] => 17922823
[patent_doc_number] => 11466056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Herpesvirus with modified glycoprotein D
[patent_app_type] => utility
[patent_app_number] => 16/307719
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 26200
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307719 | Herpesvirus with modified glycoprotein D | Jun 7, 2017 | Issued |
Array
(
[id] => 17281838
[patent_doc_number] => 11198859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of same
[patent_app_type] => utility
[patent_app_number] => 16/098278
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 11163
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098278 | Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of same | May 23, 2017 | Issued |
Array
(
[id] => 16383433
[patent_doc_number] => 10808256
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Systems and methods for untargeted metabolomic screening
[patent_app_type] => utility
[patent_app_number] => 15/602917
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 39
[patent_no_of_words] => 11230
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602917
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/602917 | Systems and methods for untargeted metabolomic screening | May 22, 2017 | Issued |
Array
(
[id] => 15264797
[patent_doc_number] => 20190381132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF IONIZING RADIATION RESISTANT TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/488101
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488101 | METHODS AND COMPOSITIONS FOR TREATMENT OF IONIZING RADIATION RESISTANT TUMORS | May 16, 2017 | Abandoned |
Array
(
[id] => 16376641
[patent_doc_number] => 20200325483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => SAFE DELIVERY OF CRISPR AND OTHER GENE THERAPIES TO LARGE FRACTIONS OF SOMATIC CELLS IN HUMANS AND ANIMALS
[patent_app_type] => utility
[patent_app_number] => 16/097886
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097886 | SAFE DELIVERY OF CRISPR AND OTHER GENE THERAPIES TO LARGE FRACTIONS OF SOMATIC CELLS IN HUMANS AND ANIMALS | May 11, 2017 | Abandoned |
Array
(
[id] => 11944452
[patent_doc_number] => 20170248602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 15/593727
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 74292
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15593727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/593727 | Immuno-based retargeted endopeptidase activity assays | May 11, 2017 | Issued |
Array
(
[id] => 12238512
[patent_doc_number] => 20180071375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'Methods and Compositions for the Treatment of Symptoms of Complex Regional Pain Syndrome'
[patent_app_type] => utility
[patent_app_number] => 15/593124
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3704
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15593124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/593124 | Methods and Compositions for the Treatment of Symptoms of Complex Regional Pain Syndrome | May 10, 2017 | Abandoned |
Array
(
[id] => 16613953
[patent_doc_number] => 20210032606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => DOXA PROTEIN MUTANT, AND CODING GENE AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/301377
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301377 | DoxA protein mutant, and coding gene and applications thereof | May 7, 2017 | Issued |
Array
(
[id] => 15538363
[patent_doc_number] => 10568941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
[patent_app_type] => utility
[patent_app_number] => 15/585927
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27650
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585927
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/585927 | Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of iduronate-2-sulfatase | May 2, 2017 | Issued |
Array
(
[id] => 15915761
[patent_doc_number] => 10655111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Modulation of lipid metabolism for protein production
[patent_app_type] => utility
[patent_app_number] => 15/585570
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 28888
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585570
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/585570 | Modulation of lipid metabolism for protein production | May 2, 2017 | Issued |
Array
(
[id] => 14295005
[patent_doc_number] => 10287620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Digital polymerase fidelity assay
[patent_app_type] => utility
[patent_app_number] => 15/581401
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 11646
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581401
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581401 | Digital polymerase fidelity assay | Apr 27, 2017 | Issued |
Array
(
[id] => 12002242
[patent_doc_number] => 20170306397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'alpha-Hemolysin Variants and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/492214
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12639
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492214 | Alpha-hemolysin variants and uses thereof | Apr 19, 2017 | Issued |
Array
(
[id] => 14963623
[patent_doc_number] => 20190309290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => Improved Methods for Modification of Target Nucleic Acids
[patent_app_type] => utility
[patent_app_number] => 16/097300
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097300 | Methods for modification of target nucleic acids | Apr 19, 2017 | Issued |
Array
(
[id] => 14407477
[patent_doc_number] => 20190169582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Compositions and Methods for Pesticide Degradation
[patent_app_type] => utility
[patent_app_number] => 16/092697
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092697 | Compositions and methods for pesticide degradation | Apr 10, 2017 | Issued |
Array
(
[id] => 14498073
[patent_doc_number] => 20190192691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => REGULATED BIOCIRCUIT SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/092829
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1440705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092829 | Regulated biocircuit systems | Apr 10, 2017 | Issued |
Array
(
[id] => 14261781
[patent_doc_number] => 10280443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Method for purifying target protein
[patent_app_type] => utility
[patent_app_number] => 15/480719
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 32
[patent_no_of_words] => 13064
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480719
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480719 | Method for purifying target protein | Apr 5, 2017 | Issued |
Array
(
[id] => 11987763
[patent_doc_number] => 20170291918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'METHOD FOR PURIFYING PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 15/480881
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12588
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480881
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480881 | METHOD FOR PURIFYING PROTEIN | Apr 5, 2017 | Abandoned |
Array
(
[id] => 11948262
[patent_doc_number] => 20170252414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Compositions and Methods for Treating Pathological Calcification and Ossification'
[patent_app_type] => utility
[patent_app_number] => 15/466401
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26688
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15466401
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/466401 | Compositions and methods for treating pathological calcification and ossification | Mar 21, 2017 | Issued |